目次

Chapter- 1: Introduction
Study Goals and Objectives
Scope of This Report
Methodology and Information Sources
What's New in This Update?
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Bioengineered Protein Drugs, by Drug Type, Through 2027
Figure Summary : Global Market for Bioengineered Protein Drugs, by Drug Type, 2019-2027

Chapter- 3: Market and Technology Background
Protein Drugs Overview
Bioengineered Protein Drugs
Manufacturing Technologies

Chapter- 4: Market Dynamics
Market Drivers
Market Challenges

Chapter- 5: Market Breakdown by Drug Type
Overview
Monoclonal Antibodies (mAbs)
Peptide Hormones
Vaccines
Fusion Proteins
Blood Factors
Peptide Antibiotics
Cytokines
Therapeutic Enzymes
Global Market for Bioengineered Protein Drugs, by Type

Chapter- 6: Market Breakdown by Disease
Overview
Autoimmune Diseases and Other Immunodeficiency Disorders
Solid Tumors
Diabetes
Infectious Diseases
Blood Disorders
Growth Hormone Disorders, Enzyme Deficiency Disorders, and Infertility
Others
Global Market for Bioengineered Protein Drugs, by Disease

Chapter- 7: Market Breakdown by Region
Global Markets for Bioengineered Protein Drugs, by Region

Chapter- 8: Regulatory Aspects and New Approvals
New Approvals

Chapter- 9: Competitive Landscape
Overview
Blockbuster Bioengineered Protein Pharmaceutical Brands
Monoclonal Antibodies
Peptide Hormones
Vaccines (Excluding COVID-19)
Blood Factors and Peptide Antibiotics
Fusion Proteins
Cytokines
Therapeutic Enzymes

Chapter- 10: Emerging Trends/Upcoming Technologies in the Market
Bi- and Multi-Specific Antibodies
Key Trends in Biopharmaceutical Industry

Chapter- 11: Impact of COVID-19 Pandemic
Overview
Impact on Bioengineered Protein Drugs Market

Chapter- 12: Company Profiles
ABBVIE INC.
ADMA BIOLOGICS INC.
AMGEN INC.
ASTRAZENECA PLC
BAYER PHARMACEUTICALS
BIONTECH SE
BRISTOL-MYERS SQUIBB
CSL LTD.
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
GRIFOLS S.A.
JOHNSON & JOHNSON
MERCK & CO., INC.
NOVARTIS AG
NOVO NORDISK A/S
OCTAPHARMA AG
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
SANOFI
TAKEDA PHARMACEUTICAL CO., LTD.